SkyOak Wealth’s NRC Health Common Stock NRC Stock Holding History

SkyOak Wealth’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,137	Closed	-$213K	–	262
2021 Q4	$213K	Buy	+5,137	New	+$223K	0.05%	223

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Touchstone Capital Pittsburgh, Pennsylvania $195M AUM

SkyOak Wealth's NRC Position: Q1 2022 in Review

SkyOak Wealth sold out of NRC Health Common Stock (NRC) in Q1 2022, closing a stake of 5,137 shares — an estimated $213K sold.

SkyOak Wealth first reported a position in NRC in Q4 2021 and held it in 1 quarter. The position peaked at $213K in Q4 2021. 116 funds tracked by Wall St. Rank hold NRC as of Q1 2022.

SkyOak Wealth reported no remaining NRC Health Common Stock position as of Q1 2022 after selling out during the quarter.
SkyOak Wealth sold 5,137 NRC Health Common Stock shares in Q1 2022, an estimated $213K.
SkyOak Wealth first reported a position in NRC Health Common Stock in Q4 2021 and held it in 1 quarter.
SkyOak Wealth's NRC Health Common Stock position peaked at $213K in Q4 2021.
116 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2022.

Based on SkyOak Wealth's 13F filing for Q1 2022, filed 18 Apr 2022.